Assess the effect of clinical pharmacy services on pediatric patient outcomes, including hospital readmissions and quality of life

It has been demonstrated that clinical pharmacy services enhance patient outcomes across a range of demographics. It is unknown, therefore, how these services affect the results of pediatric patients. to evaluate how clinical pharmacy services affect pediatric patients' quality of life and hospital readmissions. Clinical pharmacy services can enhance quality of life and decrease readmissions to hospitals for pediatric patients. The inclusion of clinical pharmacy services in pediatric care is supported by these findings. The current dissertation focuses on the quality of prescribing practices and the monitoring of medication safety, specifically the surveillance of these practices once regulatory bodies have determined that the drugs' efficacy, quality, and safety are sufficiently established for their use in clinical practice. The thalidomide tragedy in the early 1960s raised awareness of the dangers of medicines. In addition to strict approval processes, a plan was created to keep an eye on the safety of marketed medications because of the significant increase in risk. Pharmacovigilance is in charge of the scheme's theoretical foundation as well as its actual execution. The primary foundation of an implementation pharmacovigilance approach is a (spontaneous) reporting system that allows medical practitioners to report any suspicions of adverse drug reactions (ADRs), which are then investigated. This thesis examines the quality of prescribing practices and pharmacovigilance, including what they involve and how they might be enhanced.